NKTR
Nektar Therapeutics
Price:  
1.36 
USD
Volume:  
1,970,173.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR Probability of Bankruptcy

The Probability of Bankruptcy of Nektar Therapeutics (NKTR) is -% . This number represents the probability that NKTR will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating NKTR's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

NKTR - ESG ratings

ESG ratings are directly linked to the cost of capital and NKTR's ability to raise funding, both of which can significantly affect the probability of Nektar Therapeutics going bankrupt.

ESG Score 39.99
Environment Score 7.05
Social Score 50.00
Governance Score 62.91
Returns
Historical Returns (5 day) -21.02%
Historical Returns (MTD) 32.73%
Historical Returns (YTD) 119.47%
Historical Returns (13 week) 125.45%
Historical Returns (26 week) 130.48%
Historical Returns (52 week) 43.99%
Efficiency
Asset Turnover 0.19
Receiveable Turnover 25.01
Gross Margin 69.51%
Operating Margin -140.30%
Pretax Margin -176.29%
Net Margin -176.17%
Return on Asset (ROA) -58.22
Return on Equity (ROE) -151.58
Return on Investments (ROI) -151.58
Price Metrics
Market Cap (M) 249.72
Enterprise Value (M)
52 Week High 1.75
52 Week Low 0.41
Beta 1.04
Average Volume (10 day) 0.68
Average Volume (3 month) 0.48
Price / Earnings (P/E)
Price / Sales (P/S) 2.79
Earnings
EPS -1.46
Revenue CAGR (5 year) -40.35%
Risk
Current Ratio 6.45
Quick Ratio 6.14